Abstract
Two decades of linkage and association studies with candidate genes have attempted to decipher the genetic contributions of complex behavioral disorders such as Schizophrenia and Substance Use Disorders with only limited success. We suggest refining these efforts by: 1) using association studies on epidemiologically sound, general population samples with large sample sizes (2000 - 5000) to detect small effect loci, 2) developing continuous behavioral measures that “cut at natures joint”, 3) capitalizing on DNA haplotypes showing evidence of positive selection as “candidate gene” regions and 4) integrating the results with translational biological methodologies. We review our studies of a large, conserved Xq13 haplotype and discuss directions for future studies in genetic dissection integrating across complementary linkage, association, and microarray strategies.
Keywords: microarray strategies, DNA haplotypes, Schizophrenia
Current Genomics
Title: Refining Genetic Approaches for Identifying Behavioral Loci
Volume: 5 Issue: 2
Author(s): Robert A Philibert, Remi J Cadoret and Howard K Gershenfeld
Affiliation:
Keywords: microarray strategies, DNA haplotypes, Schizophrenia
Abstract: Two decades of linkage and association studies with candidate genes have attempted to decipher the genetic contributions of complex behavioral disorders such as Schizophrenia and Substance Use Disorders with only limited success. We suggest refining these efforts by: 1) using association studies on epidemiologically sound, general population samples with large sample sizes (2000 - 5000) to detect small effect loci, 2) developing continuous behavioral measures that “cut at natures joint”, 3) capitalizing on DNA haplotypes showing evidence of positive selection as “candidate gene” regions and 4) integrating the results with translational biological methodologies. We review our studies of a large, conserved Xq13 haplotype and discuss directions for future studies in genetic dissection integrating across complementary linkage, association, and microarray strategies.
Export Options
About this article
Cite this article as:
Philibert A Robert, Cadoret J Remi and Gershenfeld K Howard, Refining Genetic Approaches for Identifying Behavioral Loci, Current Genomics 2004; 5 (2) . https://dx.doi.org/10.2174/1389202043489935
DOI https://dx.doi.org/10.2174/1389202043489935 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Current Diabetes Reviews Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
Current Drug Safety PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Current Drug Metabolism Portal Vein Embolization: A Preoperative Approach to Improve the Safety of Major Hepatic Resection
Current Medical Imaging Linagliptin: A Novel Methylxanthin Based Approved Dipeptidyl Peptidase-4 Inhibitor
Current Drug Targets Anti Diabetic Effect of Cherries in Alloxan Induced Diabetic Rats
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Current Vascular Pharmacology Diabetes Mellitus as a Risk Factor for Cancer: Stress or Viral Etiology?
Infectious Disorders - Drug Targets PACAP in the Glucose and Energy Homeostasis: Physiological Role and Therapeutic Potential
Current Pharmaceutical Design Metabolic Complications and Kidney Transplantation: Focus on Glycaemia and Dyslipidaemia
Current Vascular Pharmacology Patent Selections:
Recent Patents on Biomarkers Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Interactions of Biologically Active Factors and Vascular Mediators During Hypertension in Pregnancy
Current Hypertension Reviews Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases
Current Drug Targets The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Current Understanding of the Mechanisms by which Membrane-Active Peptides Permeate and Disrupt Model Lipid Membranes
Current Topics in Medicinal Chemistry Cognitive Dysfunction in Depression: Lessons Learned from Animal Models
CNS & Neurological Disorders - Drug Targets